Literature DB >> 15879112

Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells.

Isam W Nasr1, Yinong Wang, Ge Gao, Songyan Deng, Lonnette Diggs, David M Rothstein, George Tellides, Fadi G Lakkis, Zhenhua Dai.   

Abstract

Immune responses are suppressed in immunologically privileged sites, which may provide a unique opportunity to prolong allograft survival. However, it is unknown whether testicular immune privilege promotes transplantation tolerance. Mechanisms underlying immune privilege are also not well understood. Here we found that islet transplantation in the testis, an immunologically privileged site, generates much less memory CD8(+) T cells but induces more Ag-specific CD4(+)CD25(+) regulatory T cells than in a conventional site. These CD4(+)CD25(+) cells exhibited the suppression of alloimmune responses in vivo and in vitro. Despite the immune regulation, intratesticular islet allografts all were rejected within 42 days after transplantation although they survived longer than renal subcapsular islet allografts. However, blocking CD40/CD40L costimulation induced the tolerance of intratesticular, but not renal subcapsular, islet allografts. Tolerance to intratesticular islet allografts spread to skin allografts in the non-privileged sites. Either transfer of memory CD8(+) T cells or deletion of CD25(+) T cells in vivo broke islet allograft tolerance. Thus, transplantation tolerance requires both costimulatory blockade, which suppresses acute allograft rejection, and a favorable balance between memory and regulatory T cells that could favorably prevent late allograft failure. These findings reveal novel mechanisms of immune privilege and provide direct evidence that testicular immune privilege fosters the induction of transplantation tolerance to allografts in both immunologically privileged and non-privileged sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879112     DOI: 10.4049/jimmunol.174.10.6161

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Alternative transplantation sites for pancreatic islet grafts.

Authors:  Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

2.  A Method for Performing Islet Transplantation Using Tissue-Engineered Sheets of Islets and Mesenchymal Stem Cells.

Authors:  Masataka Hirabaru; Tamotsu Kuroki; Tomohiko Adachi; Amane Kitasato; Shinichiro Ono; Takayuki Tanaka; Hajime Matsushima; Yusuke Sakai; Akihiko Soyama; Masaaki Hidaka; Kosho Yamanouchi; Mitsuhisa Takatsuki; Teruo Okano; Susumu Eguchi
Journal:  Tissue Eng Part C Methods       Date:  2015-07-23       Impact factor: 3.056

Review 3.  Testicular defense systems: immune privilege and innate immunity.

Authors:  Shutao Zhao; Weiwei Zhu; Shepu Xue; Daishu Han
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

4.  Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance.

Authors:  Kenneth S K Tung; Jessica Harakal; Hui Qiao; Claudia Rival; Jonathan C H Li; Alberta G A Paul; Karen Wheeler; Patcharin Pramoonjago; Constance M Grafer; Wei Sun; Robert D Sampson; Elissa W P Wong; Prabhakara P Reddi; Umesh S Deshmukh; Daniel M Hardy; Huanghui Tang; C Yan Cheng; Erwin Goldberg
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

5.  Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts.

Authors:  Mithun Khattar; Ronghai Deng; Barry D Kahan; Paul M Schroder; Tammy Phan; Lynne P Rutzky; Stanislaw M Stepkowski
Journal:  Transplantation       Date:  2013-04-15       Impact factor: 4.939

6.  Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.

Authors:  P Thompson; I R Badell; M Lowe; A Turner; J Cano; J Avila; A Azimzadeh; X Cheng; R N Pierson; B Johnson; J Robertson; M Song; F Leopardi; E Strobert; G Korbutt; G Rayat; R Rajotte; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2012-03-28       Impact factor: 8.086

7.  Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone.

Authors:  Undine Schubert; Janine Schmid; Susann Lehmann; Xian Y Zhang; Henning Morawietz; Norman L Block; Waldemar Kanczkowski; Andrew V Schally; Stefan R Bornstein; Barbara Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

Review 8.  Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance.

Authors:  Edmond J Yunis; Joaquin Zuniga; Viviana Romero; Emilio J Yunis
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 9.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

10.  Manipulating IL-2 availability amid presentation of donor MHC antigens suppresses murine alloimmune responses by inducing regulatory T cells.

Authors:  Shuzi Zhang; Hehua Dai; Ni Wan; Yolonda Moore; Zhenhua Dai
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.